FindTrial
Sign In

The Risk assessment and clinical application of quantitative bone ultrasound and multi-omics features in preterm infants with metabolic bone disease

The Risk assessment and clinical application of quantitative bone ultrasound and multi-omics features in preterm infants with metabolic bone disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093277
Enrollment
Unknown
Registered
2024-12-02
Start date
2023-06-01
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolic bone disease

Interventions

Group of metabolic bone disease:None
Control group:None

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Single-born premature infants; 2.The guardian's consent to participate in the study and signing of the informed consent form.

Exclusion criteria

Exclusion criteria: Newborns with complex congenital heart disease and genetic metabolic disorders.

Design outcomes

Primary

MeasureTime frame
Metabolic bone disease;—

Secondary

MeasureTime frame
Speed of Sound(SOS);Broadband ultrasound attenuation(BUA);Bone index(BQI);—

Countries

China

Contacts

Public ContactQi Zhang

China-Japan Friendship Hospital

zhangqikeyan@163.com+86 135 5220 6651

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026